chr16-20346076-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003361.4(UMOD):​c.1182+50C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.573 in 1,568,894 control chromosomes in the GnomAD database, including 274,825 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.48 ( 19790 hom., cov: 33)
Exomes 𝑓: 0.58 ( 255035 hom. )

Consequence

UMOD
NM_003361.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.336

Publications

9 publications found
Variant links:
Genes affected
UMOD (HGNC:12559): (uromodulin) The protein encoded by this gene is the most abundant protein in mammalian urine under physiological conditions. Its excretion in urine follows proteolytic cleavage of the ectodomain of its glycosyl phosphatidylinosital-anchored counterpart that is situated on the luminal cell surface of the loop of Henle. This protein may act as a constitutive inhibitor of calcium crystallization in renal fluids. Excretion of this protein in urine may provide defense against urinary tract infections caused by uropathogenic bacteria. Defects in this gene are associated with the renal disorders medullary cystic kidney disease-2 (MCKD2), glomerulocystic kidney disease with hyperuricemia and isosthenuria (GCKDHI), and familial juvenile hyperuricemic nephropathy (FJHN). Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2013]
UMOD Gene-Disease associations (from GenCC):
  • autosomal dominant medullary cystic kidney disease with or without hyperuricemia
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • glomerulocystic kidney disease with hyperuricemia and isosthenuria
    Inheritance: AD Classification: DEFINITIVE Submitted by: Laboratory for Molecular Medicine
  • familial juvenile hyperuricemic nephropathy type 1
    Inheritance: AD, Unknown Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • autosomal dominant medullary cystic kidney disease with hyperuricemia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 16-20346076-G-A is Benign according to our data. Variant chr16-20346076-G-A is described in ClinVar as Benign. ClinVar VariationId is 1279719.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.637 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
UMODNM_003361.4 linkc.1182+50C>T intron_variant Intron 5 of 10 ENST00000396138.9 NP_003352.2 P07911-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
UMODENST00000396138.9 linkc.1182+50C>T intron_variant Intron 5 of 10 5 NM_003361.4 ENSP00000379442.5 P07911-1X6RBG4
UMODENST00000396134.6 linkc.1281+50C>T intron_variant Intron 6 of 11 2 ENSP00000379438.2 P07911-5
UMODENST00000570689.5 linkc.1182+50C>T intron_variant Intron 5 of 10 5 ENSP00000460548.1 P07911-1

Frequencies

GnomAD3 genomes
AF:
0.476
AC:
72404
AN:
151976
Hom.:
19788
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.264
Gnomad AMI
AF:
0.508
Gnomad AMR
AF:
0.397
Gnomad ASJ
AF:
0.588
Gnomad EAS
AF:
0.0785
Gnomad SAS
AF:
0.324
Gnomad FIN
AF:
0.577
Gnomad MID
AF:
0.535
Gnomad NFE
AF:
0.642
Gnomad OTH
AF:
0.498
GnomAD2 exomes
AF:
0.480
AC:
116820
AN:
243604
AF XY:
0.490
show subpopulations
Gnomad AFR exome
AF:
0.249
Gnomad AMR exome
AF:
0.302
Gnomad ASJ exome
AF:
0.594
Gnomad EAS exome
AF:
0.0801
Gnomad FIN exome
AF:
0.585
Gnomad NFE exome
AF:
0.636
Gnomad OTH exome
AF:
0.526
GnomAD4 exome
AF:
0.583
AC:
826411
AN:
1416802
Hom.:
255035
Cov.:
24
AF XY:
0.578
AC XY:
407123
AN XY:
703946
show subpopulations
African (AFR)
AF:
0.251
AC:
8147
AN:
32516
American (AMR)
AF:
0.313
AC:
13792
AN:
44120
Ashkenazi Jewish (ASJ)
AF:
0.599
AC:
15398
AN:
25708
East Asian (EAS)
AF:
0.0580
AC:
2275
AN:
39230
South Asian (SAS)
AF:
0.357
AC:
30330
AN:
84952
European-Finnish (FIN)
AF:
0.589
AC:
31051
AN:
52744
Middle Eastern (MID)
AF:
0.509
AC:
2193
AN:
4312
European-Non Finnish (NFE)
AF:
0.644
AC:
691540
AN:
1074650
Other (OTH)
AF:
0.541
AC:
31685
AN:
58570
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
16265
32529
48794
65058
81323
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17738
35476
53214
70952
88690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.476
AC:
72417
AN:
152092
Hom.:
19790
Cov.:
33
AF XY:
0.463
AC XY:
34453
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.263
AC:
10935
AN:
41500
American (AMR)
AF:
0.396
AC:
6054
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.588
AC:
2039
AN:
3470
East Asian (EAS)
AF:
0.0781
AC:
404
AN:
5174
South Asian (SAS)
AF:
0.326
AC:
1567
AN:
4812
European-Finnish (FIN)
AF:
0.577
AC:
6107
AN:
10588
Middle Eastern (MID)
AF:
0.524
AC:
154
AN:
294
European-Non Finnish (NFE)
AF:
0.642
AC:
43648
AN:
67958
Other (OTH)
AF:
0.497
AC:
1049
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1700
3401
5101
6802
8502
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
630
1260
1890
2520
3150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.591
Hom.:
21666
Bravo
AF:
0.450
Asia WGS
AF:
0.206
AC:
718
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 25, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
2.6
DANN
Benign
0.79
PhyloP100
-0.34
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4506906; hg19: chr16-20357398; COSMIC: COSV56775480; COSMIC: COSV56775480; API